Filing Details
- Accession Number:
- 0001179110-15-007533
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-05-11 17:03:18
- Reporting Period:
- 2015-05-07
- Filing Date:
- 2015-05-11
- Accepted Time:
- 2015-05-11 17:03:18
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 815094 | Abiomed Inc | ABMD | Surgical & Medical Instruments & Apparatus (3841) | 042743260 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1456804 | G Michael Howley | C/O Abiomed, Inc. 22 Cherry Hill Drive Danvers MA 01923 | Vp, Global Sales & Marketing | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, $.01 Par Value | Acquisiton | 2015-05-07 | 10,699 | $5.23 | 96,282 | No | 4 | M | Direct | |
| Common Stock, $.01 Par Value | Disposition | 2015-05-07 | 9,900 | $70.00 | 86,382 | No | 4 | S | Direct | |
| Common Stock, $.01 Par Value | Disposition | 2015-05-07 | 1,528 | $70.81 | 84,854 | No | 4 | S | Direct | |
| Common Stock, $.01 Par Value | Disposition | 2015-05-07 | 986 | $71.85 | 83,868 | No | 4 | S | Direct | |
| Common Stock, $.01 Par Value | Disposition | 2015-05-07 | 484 | $73.00 | 83,384 | No | 4 | S | Direct | |
| Common Stock, $.01 Par Value | Disposition | 2015-05-07 | 84 | $73.78 | 83,300 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2015-05-07 | 10,699 | $0.00 | 10,699 | $5.23 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 14,301 | 2009-03-05 | 2019-03-05 | No | 4 | M | Direct |
Reported Derivative Holdings
| Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | $10.03 | 2011-06-03 | 2020-06-03 | 0 | 30,000 | Direct |
| Common Stock | Stock Option (Right to buy) | $22.44 | 2013-05-22 | 2022-05-22 | 0 | 25,000 | Direct |
| Common Stock | Stock Option (Right to Buy) | $23.15 | 2014-05-14 | 2023-05-14 | 0 | 25,000 | Direct |
| Common Stock | Stock Option (Right to Buy) | $21.55 | 2015-05-14 | 2024-05-14 | 0 | 25,000 | Direct |
| Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|
| 2020-06-03 | 0 | 30,000 | Direct |
| 2022-05-22 | 0 | 25,000 | Direct |
| 2023-05-14 | 0 | 25,000 | Direct |
| 2024-05-14 | 0 | 25,000 | Direct |
Footnotes
- Grant to reporting person of option to buy the number of shares of common stock set forth on Table II, Column 7, under the Abiomed, Inc. 2008 Stock Incentive Plan.
- These options become exerciseable in annual 25% increments, commencing on the date shown forth in Table II, Column 6.
- These options become exercisable in annual 33-1/3% increments, commencing on the date shown in Table II, Column 6.
- Sale of common stock pursuant to reporting owner's 10b5-1 plan.
- This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $69.5000 and $70.4900. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $70.5000 and $71.3800. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $71.5200 and $72.3900. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $72.5300 and $73.4100. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $73.5300 and $73.9000. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
Billionaire Hedge Funds
